A211801, "BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation,"

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Prevention

Locations

University of Colorado Hospital

Principal Investigator
Photograph of Marie Wood,  MD

Marie Wood, MD

Study ID

Protocol Number: 22-2040

More information available at ClinicalTrials.gov: NCT04711109

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers